These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 9460933

  • 1. An efficient selection system for packaging herpes simplex virus amplicons.
    Zhang X, O'Shea H, Entwisle C, Boursnell M, Efstathiou S, Inglis S.
    J Gen Virol; 1998 Jan; 79 ( Pt 1)():125-31. PubMed ID: 9460933
    [Abstract] [Full Text] [Related]

  • 2. A novel 'piggyback' packaging system for herpes simplex virus amplicon vectors.
    Pechan PA, Fotaki M, Thompson RL, Dunn R, Chase M, Chiocca EA, Breakefield XO.
    Hum Gene Ther; 1996 Oct 20; 7(16):2003-13. PubMed ID: 8930661
    [Abstract] [Full Text] [Related]

  • 3. Improved helper virus-free packaging system for HSV amplicon vectors using an ICP27-deleted, oversized HSV-1 DNA in a bacterial artificial chromosome.
    Saeki Y, Fraefel C, Ichikawa T, Breakefield XO, Chiocca EA.
    Mol Ther; 2001 Apr 20; 3(4):591-601. PubMed ID: 11319922
    [Abstract] [Full Text] [Related]

  • 4. Combined HSV-1 recombinant and amplicon piggyback vectors: replication-competent and defective forms, and therapeutic efficacy for experimental gliomas.
    Pechan PA, Herrlinger U, Aghi M, Jacobs A, Breakefield XO.
    J Gene Med; 1999 Apr 20; 1(3):176-85. PubMed ID: 10738566
    [Abstract] [Full Text] [Related]

  • 5. Increased transcomplementation properties of plasmids carrying HSV-1 origin of replication and packaging signals.
    Berthomme H, Fournel S, Epstein AL.
    Virology; 1996 Feb 15; 216(2):437-43. PubMed ID: 8607275
    [Abstract] [Full Text] [Related]

  • 6. Herpes simplex virus type 1 DNA amplified as bacterial artificial chromosome in Escherichia coli: rescue of replication-competent virus progeny and packaging of amplicon vectors.
    Saeki Y, Ichikawa T, Saeki A, Chiocca EA, Tobler K, Ackermann M, Breakefield XO, Fraefel C.
    Hum Gene Ther; 1998 Dec 10; 9(18):2787-94. PubMed ID: 9874276
    [Abstract] [Full Text] [Related]

  • 7. Examination of conditions affecting the efficiency of HVS-1 amplicon packaging.
    Wu X, Leduc Y, Cynader M, Tufaro F.
    J Virol Methods; 1995 Mar 10; 52(1-2):219-29. PubMed ID: 7769035
    [Abstract] [Full Text] [Related]

  • 8. In vivo complementation studies of a glycoprotein H-deleted herpes simplex virus-based vector.
    Speck PG, Efstathiou S, Minson AC.
    J Gen Virol; 1996 Oct 10; 77 ( Pt 10)():2563-8. PubMed ID: 8887491
    [Abstract] [Full Text] [Related]

  • 9. An HSV amplicon-based helper system for helper-dependent adenoviral vectors.
    Kubo S, Saeki Y, Chiocca EA, Mitani K.
    Biochem Biophys Res Commun; 2003 Aug 08; 307(4):826-30. PubMed ID: 12878185
    [Abstract] [Full Text] [Related]

  • 10. Gene delivery using helper virus-free HSV-1 amplicon vectors.
    Fraefel C.
    Curr Protoc Hum Genet; 2002 Aug 08; Chapter 12():Unit 12.12. PubMed ID: 18428323
    [Abstract] [Full Text] [Related]

  • 11. An enhanced packaging system for helper-dependent herpes simplex virus vectors.
    Stavropoulos TA, Strathdee CA.
    J Virol; 1998 Sep 08; 72(9):7137-43. PubMed ID: 9696807
    [Abstract] [Full Text] [Related]

  • 12. HSV/AAV hybrid amplicon vectors extend transgene expression in human glioma cells.
    Johnston KM, Jacoby D, Pechan PA, Fraefel C, Borghesani P, Schuback D, Dunn RJ, Smith FI, Breakefield XO.
    Hum Gene Ther; 1997 Feb 10; 8(3):359-70. PubMed ID: 9048203
    [Abstract] [Full Text] [Related]

  • 13. Expression of vhs and VP16 during HSV-1 helper virus-free amplicon packaging enhances titers.
    Bowers WJ, Howard DF, Brooks AI, Halterman MW, Federoff HJ.
    Gene Ther; 2001 Jan 10; 8(2):111-20. PubMed ID: 11313780
    [Abstract] [Full Text] [Related]

  • 14. Gene delivery using helper virus-free HSV-1 amplicon vectors.
    Fraefel C.
    Curr Protoc Neurosci; 2007 Jul 10; Chapter 4():Unit 4.14. PubMed ID: 18428655
    [Abstract] [Full Text] [Related]

  • 15. Helper virus-free herpes simplex virus type 1 amplicon vectors for granulocyte-macrophage colony-stimulating factor-enhanced vaccination therapy for experimental glioma.
    Herrlinger U, Jacobs A, Quinones A, Woiciechowsky C, Sena-Esteves M, Rainov NG, Fraefel C, Breakefield XO.
    Hum Gene Ther; 2000 Jul 01; 11(10):1429-38. PubMed ID: 10910140
    [Abstract] [Full Text] [Related]

  • 16. Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo.
    Jacobs A, Tjuvajev JG, Dubrovin M, Akhurst T, Balatoni J, Beattie B, Joshi R, Finn R, Larson SM, Herrlinger U, Pechan PA, Chiocca EA, Breakefield XO, Blasberg RG.
    Cancer Res; 2001 Apr 01; 61(7):2983-95. PubMed ID: 11306477
    [Abstract] [Full Text] [Related]

  • 17. A novel approach for herpes simplex virus type 1 amplicon vector production, using the Cre-loxP recombination system to remove helper virus.
    Logvinoff C, Epstein AL.
    Hum Gene Ther; 2001 Jan 20; 12(2):161-7. PubMed ID: 11177553
    [Abstract] [Full Text] [Related]

  • 18. Murine Bone Marrow-Derived Dendritic Cells Transduced by Light-Helper-Dependent Herpes Simplex Virus-1 Amplicon Vector Acquire a Mature Dendritic Cell Phenotype.
    Oz-Arslan D, Tsitoura E, Kazazi D, Kouvatsis V, Epstein AL, Mavromara P.
    Hum Gene Ther Methods; 2015 Jun 20; 26(3):93-102. PubMed ID: 26046494
    [Abstract] [Full Text] [Related]

  • 19. Generation of high-titer defective HSV-1 vectors.
    Lim F, Neve RL.
    Curr Protoc Neurosci; 2001 May 20; Chapter 4():Unit 4.13. PubMed ID: 18428477
    [Abstract] [Full Text] [Related]

  • 20. Improved packaging system for generation of high-level noncytotoxic HSV-1 amplicon vectors using Cre-loxP site-specific recombination to delete the packaging signals of defective helper genomes.
    Zaupa C, Revol-Guyot V, Epstein AL.
    Hum Gene Ther; 2003 Jul 20; 14(11):1049-63. PubMed ID: 12885345
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.